Predicting Disease Course in Inflammatory Bowel Disease using Health Administrative Data
Creators: name: Salama, Dina
Publisher: name: Université d'Ottawa / University of Ottawa
Year: 2021
Subjects: Inflammatory bowel disease
Health administrative data
Disease severity
Partial proportional odds
Ordinal logistic regression

description: Background: Investigators are often interested in using population-level health administrative data in inflammatory bowel disease (IBD) patients to study disease outcomes, risk factors and treatment effects to enhance knowledge, shape clinical practice and influence health care policy. A major limitation of using health administrative data for these purposes is the lack of detailed clinical data to adjust for the confounding effects of differential disease severity on observed associations. Methods to account for disease severity using administrative variables would offer a major advance to population-level studies in IBD patients. Thus, in this study we aimed to use a cohort of IBD patients from The Ottawa Hospital (TOH) to validate a model that was originally developed in Manitoba for estimating clinical disease course in IBD patients through healthcare utilization measures. Objectives: The objectives of this thesis are: 1) To identify and characterize a reference cohort of IBD patients in the ambulatory clinics of four gastroenterologists from TOH on clinical disease course in the preceding year (reference cohort), based on a Manitoba definition of clinical disease course; 2) To fit a partial proportional odds (PPO) model for predicting IBD course, derived using Manitoba health administrative data, to the reference cohort of IBD patients using Ontario health administrative data; 3) To derive new PPO models of IBD disease course for the reference cohort using Ontario administrative variables and compare model performance; and 4) To apply the models to the Ontario Crohn’s and Colitis cohort (OCCC) to estimate IBD course in Ontario, and compare the distribution to that of the Manitoba IBD population.Methods: We first identified a reference cohort of IBD patients in Ontario from the outpatient clinics at TOH during fiscal year 2015. Through chart review, we classified these patients into one of four clinical disease categories (remission, mild, moderate, or severe) using the Manitoba definition. We linked these patients to Ontario health administrative datasets. Given slight differences in data structure and coding between Manitoba and Ontario, we were unable to directly test the Manitoba model and instead fit a PPO model to the Ontario cohort using analogous administrative variables to those used in the final Manitoba model (“adapted model”). We subsequently derived new PPO models using unique Ontario administrative variables under three strategies: 1) Stepwise variable selection (“stepwise model”); 2) Forced fitting of all variables (“all-variables model”); and 3) Using a two-step modelling algorithm that considered IBD-related hospitalizations separate from other administrative variables (“two-step model”). We then compared model performance from the four strategies. Finally, we applied the models to the Ontario IBD population from 2004 to 2016 and compared model estimates to those from Manitoba. Results: We identified 963 patients with IBD from TOH outpatient clinics, of which 52.3% (n=504) were males, 64.6% (n=622) had Crohn's Disease, and 89.2% (n=859) resided in an urban setting. Based on the Manitoba definition, 64.9% of patients within our reference cohort were classified as remission, while 11.4%, 14.1%, and 9.6% were classified as mild, moderate, and severe disease course, respectively. The adapted model (c-statistic 0.77, goodness-fit p-value 0.28) performed comparably to the other models: the stepwise model (c-statistic 0.77, goodness-fit p-value 0.50), the all-variables model (c-statistic 0.77, goodness-fit p-value 0.53), and the two-step model (c-statistic 0.78, goodness-fit p-value 0.75). The adapted model also resulted in overall similar estimates with regards to the disease course distribution among the Ontario IBD population. However, on closer inspection, our two-step model, in which individuals who had been hospitalized for an IBD-related indication within the past year were assumed to have severe disease, performed better with respect to accurately classifying individuals with moderate or severe disease, without sacrificing discriminative ability. Based on the two-step model, from 2004 to 2016, 89.2-91.2% of the Ontario IBD population was in remission, 0% had mild disease, 2.4-3.2% had moderate disease, and 5.9-8.4% had severe disease. Distribution of disease course among IBD patients in Ontario differed considerably than that in Manitoba. Conclusion: In the absence of clinical information within health administrative data, we present and compare four different models that can be used to partially account for the confounding effect of disease course among IBD patients in future population-based studies using Ontario health administrative data. Given that our models did not perform as originally expected, especially with regards to accurately identifying individuals with more active disease states, we advise researchers to use these models at their own discretion.